Infective Liver Diseases
This special issue belongs to the section "Medical Microbiology".
Special Issue Information
Dear Colleagues,
There are at least five hepatitis viruses, which cause various pathogenesis, including liver diseases and extrahepatic manifestations. The number of patients with hepatitis A and E viruses is still increasing, and chronic hepatitis E virus infection is one of the serious health issues worldwide. Effective nucleos(t)ides analogues and direct-acting antivirals have been developed for hepatitis B and C virus infection, respectively; however, there are still unresolved problems, such as reactivation of hepatitis B virus (HBV), functional cure and elimination of covalently closed circular HBV (cccHBV) and the occurrence of hepatocellular carcinoma (HCC) after sustained virological response. Infectious liver diseases also includes liver abscess, infectious liver cyst, cholecystocholedocholithiasis, and other bacterial, virus or fungal infections. Infectious complications after surgery, radiofrequency ablation, percutaneous transhepatic biliary drainage and liver trauma are also important in this area. Metabolic dysfunction-associated fatty liver disease (MAFLD)/metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-associated liver disease and drug-induced liver disease also have effects on these infectious liver diseases. Molecular and genetic mechanisms should also be explored. Recent advances for the pathobiology, diagnosis modality, therapeutic options and management by multidisciplinary team approach will be discussed in this Special Issue.
Prof. Dr. Tatsuo Kanda
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hepatitis viruses
- liver abscess
- endo–hepatology
- multidisciplinary collaboration
- malaria
- schistosomiasis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

